Related Experiment Video
Updated: Aug 14, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Adjuvant effect of a 14-member macrolide antibiotic on DNA vaccine
Y Sato1, H Shishido, H Kobayashi
1Department of Internal Medicine II, Fukushima Medical University School of Medicine, Fukushima, 960-1295, Japan. med2fmc@po.sphere.ne.jp
Abstract:
Macrolide antibiotics have unique immunomodulatory actions apart from their antimicrobial properties. We examined the effect of erythromycin (EM), a 14-member macrolide, on the immune response to a DNA vaccine that induces a T-helper-1 (Th1)-biased immune response through a Th1-promoting adjuvant effect of unmethylated CpG motifs within plasmid DNA. EM enhanced Th1 responses in plasmid DNA-immunized mice as measured by antigen-specific IgG2a antibody production, interferon-gamma production by antigen-specific CD4(+) T cells, and cytotoxic T lymphocyte responses. EM augmented the accessory cell activity of unmethylated CpG DNA-stimulated antigen-presenting cells (APCs), suggesting that EM enhances Th1 responses to a DNA vaccine, possibly through augmentation of accessory cell activity of APCs stimulated with CpG motifs within plasmid DNA.
Insights
Erythromycin (EM), a macrolide antibiotic, enhances T-helper-1 (Th1) immune responses to DNA vaccines. This enhancement may occur by boosting the activity of antigen-presenting cells stimulated by CpG DNA motifs.
Area of Science:
- Immunology
- Pharmacology
- Vaccinology
Background:
- Macrolide antibiotics possess immunomodulatory effects beyond their antimicrobial actions.
- DNA vaccines utilize unmethylated CpG motifs to promote T-helper-1 (Th1)-biased immune responses.
Purpose of the Study:
- To investigate the impact of erythromycin (EM) on the immune response elicited by a DNA vaccine.
- To determine if EM influences the Th1-biased immunity induced by plasmid DNA vaccines.
Main Methods:
- Mice were immunized with a DNA vaccine containing CpG motifs.
- The effect of erythromycin (EM) on immune responses was assessed.
- Key immune markers including antibody production, cytokine release, and T cell activity were measured.
Main Results:
- Erythromycin (EM) significantly enhanced Th1 immune responses in mice vaccinated with DNA.
- Specific findings include increased antigen-specific IgG2a antibody levels and interferon-gamma production by CD4(+) T cells.
- Cytotoxic T lymphocyte responses were also augmented by EM treatment.
Conclusions:
- Erythromycin (EM) potentiates Th1-biased immune responses to DNA vaccines.
- This enhancement may be mediated by EM's ability to augment the accessory cell activity of antigen-presenting cells (APCs) stimulated by CpG DNA motifs.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics
Vaccines
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance